A randomized trial shows that a new thrombolytic agent reduces total mortality in the first 30 days after a suspected myocardial infraction by 30 percent compared with a placebo(p

• A. What was the power of study?
• B. What happened to surviving patients in next year?
• C. What percentage of patients in each group actually had a myocardial infraction?
• D. Was the trial blinded?